Decrease of lymphoproliferative response by amphetamine is mediated by dopamine from the nucleus accumbens: Influence on splenic met-enkephalin levels
-
Add time:08/18/2019 Source:sciencedirect.com
Despite the mesocorticolimbic dopaminergic pathway being one of the main substrates underlying stimulating and reinforcing effects induced by psychostimulant drugs, there is little information regarding its role in their effects at the immune level. We have previously demonstrated that acute exposure to amphetamine (5 mg/kg, i.p.) induced an inhibitory effect on the splenic T-cell proliferative response, along with an increase in the methionine(met)-enkephalin content at limbic and immune levels, 4 days after drug administration. In this study, we investigated if a possible dopamine mechanism underlies these amphetamine-induced effects by administering D1 and D2 dopaminergic antagonists or a dopaminergic terminal neurotoxin before the drug. Pre-treatment with either SCH-23390 (0.1 mg/kg, i.p.) or raclopride (0.1 mg/kg, i.p.), a D1 or D2 dopaminergic receptor antagonist, respectively, abrogated the effects of amphetamine on the lymphoproliferative response and on met-enkephalin levels of the spleen. The amphetamine-induced increase in limbic met-enkephalin content was suppressed by SCH-23390 but not by raclopride pre-treatment. Finally, an intra-accumbens 6-hydroxy-dopamine injection administered 2 weeks previously prevented amphetamine-induced effects on the lymphoproliferative response and on met-enkephalin levels in the prefrontal cortex and spleen. These findings strongly suggest that D1 and D2 dopaminergic receptors are involved in amphetamine-induced effects at immune level as regards the lymphoproliferative response and the changes in spleen met-enkephalin content, whereas limbic met-enkephalin levels were modulated only by the D1 dopaminergic receptors. In addition, this study showed that a mesolimbic component modulated amphetamine-induced effects on the immune response, as previously shown at a behavioral level.
We also recommend Trading Suppliers and Manufacturers of enkephalin, Met(2)-ProNH2(5)(N(1.5)-glucopyranosyl) (cas 113282-21-6). Pls Click Website Link as below: cas 113282-21-6 suppliers
Prev:Research paperImmunomodulation by two potent analogs of met-enkephalin
Next:Inhibition of sexual behavior in female rats by intracerebral injections of Met-enkephalin in combination with an inhibitor of enkephalin degrading enzymes☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ArticleDetection of Met-enkephalin in the CNS of the teleosts, Anguilla rostrata and Oncorhynchus kisutch08/21/2019
- Repetitive electroacupuncture causes prolonged increased met-enkephalin expression in the rVLM of conscious rats08/20/2019
- Inhibition of sexual behavior in female rats by intracerebral injections of Met-enkephalin in combination with an inhibitor of enkephalin degrading enzymes☆08/19/2019
- Research paperImmunomodulation by two potent analogs of met-enkephalin08/17/2019
- ArticleEffects of Met-enkephalin on the mechanical activity and distribution of Met-enkephalin-like immunoreactivity in the cat large intestine08/16/2019
- Perinatal ethanol exposure alters met-enkephalin levels of male and female rats08/15/2019
- Blockade of analgesic effects following systemic administration of N-methyl-kyotorphin, NMYR and arginine in mice deficient of preproenkephalin or proopiomelanocortin gene08/14/2019
- Elevated serum [Met5]-enkephalin levels correlate with improved clinical and behavioral outcomes in experimental autoimmune encephalomyelitis08/13/2019
- Original articleEnkephalin degradation in serum of patients with inflammatory bowel diseases08/12/2019


